InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
T+90 hit rate
83%
T+90 mean return
+8.2%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by King Kevin M, Director. Insider active across 2 companies, notably iRhythm Technologies, Inc.. In total, 8 disclosures have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €817k. History available since 18 June 2021. The latest transaction was disclosed on 14 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
30,612 shares0Common StockSEC:0000950170-25-073841:0
21,871 shares0Common StockSEC:0000950170-24-070902:0
17,094 shares0Common StockSEC:0001209191-23-034060:0
6,849 shares0Common StockSEC:0001209191-22-036049:0
459 shares0Common StockSEC:0001209191-22-021020:0
6,815 shares@ US$132.67210.014% mcap100.0% of flowCommon StockSEC:0001388658-22-000036:0
951 shares0Common StockSEC:0001388658-21-000112
951 shares0Common StockSEC:0001388658-21-000112:0
8 of 8 declarations
About King Kevin M
Kevin M. King is a Board Member at iRhythm Technologies, Inc. and Inogen Inc. He brings strategic and operational expertise to the leadership of the companies. As a Board Member, he is involved in key decision-making that influences growth and innovation. His experience in the medical technology sector is an asset to the companies he is involved with.
